Capabilities:

Portfolio Management

To sustain long-term growth, companies manage a number of products and candidates at different stages of maturity. However, different product profiles and the therapeutic areas they serve have disparate commercial opportunities.

Our portfolio prioritization, pipeline analysis, category franchise strategy, and technology licensing assessments provide a systematic means of optimizing development programs and product opportunities. We outline and quantify the areas of greatest opportunity for your organization and recommend actionable strategies that establish or expand your position in target markets.

Key portfolio management questions that we address:

  • Which technologies and product candidates have the greatest potential commercial value?
  • How can we broaden and deepen our therapy penetration?
  • What actions can we take to maximize return on investment for individual candidates and discoveries?
  • Which proprietary rights do we buy, co-market, license, or sell?
  • How do we balance short and long term product needs to maximize therapeutic franchise value?

We detail the value of discoveries in clinical phases, candidates in the pipeline, and products on the market. These individual and therapeutic category evaluations enable executives to make strategic investment, licensing and prioritization decisions to realize their portfolio's full potential.

[Portfolio Management]